Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

Specificity in killing pathogens is mediated by distinct repertoires of human neutrophil peptides.

Cederlund A, Agerberth B, Bergman P.

J Innate Immun. 2010;2(6):508-21. doi: 10.1159/000317665. Epub 2010 Sep 4.

2.

Differential activity of innate defense antimicrobial peptides against Nocardia species.

Rieg S, Meier B, Fähnrich E, Huth A, Wagner D, Kern WV, Kalbacher H.

BMC Microbiol. 2010 Feb 23;10:61. doi: 10.1186/1471-2180-10-61.

3.

Antimicrobial peptides: the ancient arm of the human immune system.

Wiesner J, Vilcinskas A.

Virulence. 2010 Sep-Oct;1(5):440-64. doi: 10.4161/viru.1.5.12983. Review.

PMID:
21178486
4.

Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Lee HY, Andalibi A, Webster P, Moon SK, Teufert K, Kang SH, Li JD, Nagura M, Ganz T, Lim DJ.

BMC Infect Dis. 2004 May 5;4:12.

6.

Isolation and characterisation of proline/arginine-rich cathelicidin peptides from ovine neutrophils.

Anderson RC, Yu PL.

Biochem Biophys Res Commun. 2003 Dec 26;312(4):1139-46. Erratum in: Biochem Biophys Res Commun. 2004 Feb 27;315(1):246.

PMID:
14651991
7.

Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.

Rieg S, Huth A, Kalbacher H, Kern WV.

Int J Antimicrob Agents. 2009 Feb;33(2):174-6. doi: 10.1016/j.ijantimicag.2008.07.032. Epub 2008 Oct 21.

PMID:
18945595
8.

Synthetic cationic amphiphilic α-helical peptides as antimicrobial agents.

Wiradharma N, Khoe U, Hauser CA, Seow SV, Zhang S, Yang YY.

Biomaterials. 2011 Mar;32(8):2204-12. doi: 10.1016/j.biomaterials.2010.11.054. Epub 2010 Dec 18.

PMID:
21168911
9.

Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils.

Chertov O, Michiel DF, Xu L, Wang JM, Tani K, Murphy WJ, Longo DL, Taub DD, Oppenheim JJ.

J Biol Chem. 1996 Feb 9;271(6):2935-40.

10.
11.

Candida albicans mucin Msb2 is a broad-range protectant against antimicrobial peptides.

Swidergall M, Ernst AM, Ernst JF.

Antimicrob Agents Chemother. 2013 Aug;57(8):3917-22. doi: 10.1128/AAC.00862-13. Epub 2013 Jun 3.

12.

alpha-Defensins from blood leukocytes of the monkey Papio hamadryas.

Tsvetkova EV, Aleshina GM, Shamova OV, Leonova LE, Lehrer RI, Kokryakov VN.

Biochemistry (Mosc). 2006 Aug;71(8):879-83.

PMID:
16978151
13.

Innate immune properties of selected human neuropeptides against Moraxella catarrhalis and nontypeable Haemophilus influenzae.

Augustyniak D, Jankowski A, Mackiewicz P, Skowyra A, Gutowicz J, Drulis-Kawa Z.

BMC Immunol. 2012 May 2;13:24.

14.

Effects of bacterial infection on airway antimicrobial peptides and proteins in COPD.

Parameswaran GI, Sethi S, Murphy TF.

Chest. 2011 Sep;140(3):611-617. doi: 10.1378/chest.10-2760. Epub 2011 Feb 24.

15.

MprF-mediated lysinylation of phospholipids in Staphylococcus aureus leads to protection against oxygen-independent neutrophil killing.

Kristian SA, Dürr M, Van Strijp JA, Neumeister B, Peschel A.

Infect Immun. 2003 Jan;71(1):546-9.

16.
17.

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides.

Peschel A, Otto M, Jack RW, Kalbacher H, Jung G, Götz F.

J Biol Chem. 1999 Mar 26;274(13):8405-10.

19.

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine.

Peschel A, Jack RW, Otto M, Collins LV, Staubitz P, Nicholson G, Kalbacher H, Nieuwenhuizen WF, Jung G, Tarkowski A, van Kessel KP, van Strijp JA.

J Exp Med. 2001 May 7;193(9):1067-76.

20.

Purification of peptides with differential cytolytic activities from the skin secretions of the Central American frog, Lithobates vaillanti (Ranidae).

Conlon JM, Raza H, Coquet L, Jouenne T, Leprince J, Vaudry H, King JD.

Comp Biochem Physiol C Toxicol Pharmacol. 2009 Aug;150(2):150-4. doi: 10.1016/j.cbpc.2009.04.003. Epub 2009 Apr 18.

PMID:
19379837

Supplemental Content

Support Center